Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

被引：0
作者：
Toshiaki Iwase
Kenichi Harano
Hiroko Masuda
Kumiko Kida
Kenneth R. Hess
Ying Wang
Luc Dirix
Steven J. Van Laere
Anthony Lucci
Savitri Krishnamurthy
Wendy A. Woodward
Rachel M. Layman
François Bertucci
Naoto T. Ueno
机构：
[1] The University of Texas MD Anderson Cancer Center,Morgan Welch Inflammatory Breast Cancer Research Program and Clinic
[2] The University of Texas MD Anderson Cancer Center,Section of Translational Breast Cancer Research, Department of Breast Medical Oncology
[3] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[4] The University of Texas MD Anderson Cancer Center,Department of Bioinformatics and Computational Biology
[5] University of Antwerp,Department of Oncology
[6] The University of Texas MD Anderson Cancer Center,Department of Breast Surgical Oncology
[7] The University of Texas MD Anderson Cancer Center,Department of Anatomical Pathology
[8] The University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[9] The University of Texas MD Anderson Cancer Center,Department of Breast Medical Oncology
[10] Aix-Marseille Université,Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Institut Paoli
来源：
BMC Cancer | / 20卷
关键词：
Inflammatory breast neoplasms; Estrogen receptors; Immunohistochemistry; Gene expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 192 条
  • [1] Hance KW(2005)Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute J Natl Cancer Inst 97 966-975
  • [2] Anderson WF(2007)Trends for inflammatory breast cancer: is survival improving? Oncologist 12 904-912
  • [3] Devesa SS(2006)High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients Clinical cancer research : an official journal of the American Association for Cancer Research 12 4614-4618
  • [4] Young HA(2016)Impact of estrogen receptor-beta expression on breast cancer prognosis: a meta-analysis Breast Cancer Res Treat 156 149-162
  • [5] Levine PH(2013)Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women BCR 15 R90-168
  • [6] Gonzalez-Angulo AM(2017)Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database J Cancer Res Clin Oncol 143 161-391
  • [7] Hennessy BT(2014)Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes Ann Oncol 25 384-4696
  • [8] Broglio K(2013)Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets Clin Cancer Res 19 4685-4174
  • [9] Meric-Bernstam F(2003)The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and bowel project protocol B-27 J Clin Oncol 21 4165-1242
  • [10] Cristofanilli M(2003)Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values Bioinformatics (Oxford, England) 19 1236-1561
12345678910